Daily Stock Opinions and Ratings

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Gordon Reid and Jim Cramer - Mad Money commented about whether FANG, ET, CWEN, LVS, PLTR, NRZ, STWD, IRM, IIPR, VTR, EQIX, PLD, SKT, SPG, CCI, AMT, BLDR, CMG, MRVL, BYND, DELL, DRI, NKE, COST, WDAY, ADBE, FDX, LEN, JNJ, PFE, BX, AMZN, RTX, GS, INTC, MRNA, MA, BHP, QCOM, MSFT, AAPL, PAYX, EW, WM, MDLZ, HXL, ABBV, JPM, GOOG, FCX are stocks to buy or sell.

Wednesday, September 22, 2021Tuesday, September 21, 2021Monday, September 20, 2021Friday, September 17, 2021Thursday, September 16, 2021Wednesday, September 15, 2021Tuesday, September 14, 2021
Past 12 months
Fri, Jul 3
Thu, Jul 2
Wed, Jul 1
Tue, Jun 30
Mon, Jun 29
Fri, Jun 26
Thu, Jun 25
Wed, Jun 24
Tue, Jun 23
Mon, Jun 22
Fri, Jun 19
Thu, Jun 18
Wed, Jun 17
Tue, Jun 16
Mon, Jun 15
Fri, Jun 12
Thu, Jun 11
Wed, Jun 10
Tue, Jun 9
Mon, Jun 8
Fri, Jun 5
Thu, Jun 4
Wed, Jun 3
Tue, Jun 2
Mon, Jun 1
Fri, May 29
Thu, May 28
Wed, May 27
Tue, May 26
Mon, May 25
Fri, May 22
Thu, May 21
Wed, May 20
Tue, May 19
Mon, May 18
Fri, May 15
Thu, May 14
Wed, May 13
Tue, May 12
Mon, May 11
Fri, May 8
Thu, May 7
Wed, May 6
Tue, May 5
Mon, May 4
Fri, May 1
Thu, Apr 30
Wed, Apr 29
Tue, Apr 28
Mon, Apr 27
Fri, Apr 24
Thu, Apr 23
Wed, Apr 22
Tue, Apr 21
Mon, Apr 20
Fri, Apr 17
Thu, Apr 16
Wed, Apr 15
Tue, Apr 14
Mon, Apr 13
Fri, Apr 10
Thu, Apr 9
Wed, Apr 8
Tue, Apr 7
Mon, Apr 6
Thu, Apr 2
Wed, Apr 1
Tue, Mar 31
Mon, Mar 30
Fri, Mar 27
Thu, Mar 26
Wed, Mar 25
Tue, Mar 24
Mon, Mar 23
Fri, Mar 20
Thu, Mar 19
Wed, Mar 18
Tue, Mar 17
Mon, Mar 16
Fri, Mar 13
Thu, Mar 12
Wed, Mar 11
Tue, Mar 10
Mon, Mar 9
Fri, Mar 6
Thu, Mar 5
Wed, Mar 4
Tue, Mar 3
Mon, Mar 2
Fri, Feb 27
Thu, Feb 26
Wed, Feb 25
Tue, Feb 24
Mon, Feb 23
Fri, Feb 20
Thu, Feb 19
Wed, Feb 18
Tue, Feb 17
Fri, Feb 13
Thu, Feb 12
Wed, Feb 11
Tue, Feb 10
Mon, Feb 9
Fri, Feb 6
Thu, Feb 5
Wed, Feb 4
Tue, Feb 3
Mon, Feb 2
Fri, Jan 30
Thu, Jan 29
Wed, Jan 28
Tue, Jan 27
Mon, Jan 26
Fri, Jan 23
Thu, Jan 22
Wed, Jan 21
Tue, Jan 20
Mon, Jan 19
Fri, Jan 16
Thu, Jan 15
Wed, Jan 14
Tue, Jan 13
Mon, Jan 12
Fri, Jan 9
Thu, Jan 8
Wed, Jan 7
Tue, Jan 6
Mon, Jan 5
Fri, Jan 2
Wed, Dec 31
Tue, Dec 30
Mon, Dec 29
Fri, Dec 26
Wed, Dec 24
Tue, Dec 23
Mon, Dec 22
Fri, Dec 19
Thu, Dec 18
Wed, Dec 17
Tue, Dec 16
Mon, Dec 15
Fri, Dec 12
Thu, Dec 11
Wed, Dec 10
Tue, Dec 9
Mon, Dec 8
Fri, Dec 5
Thu, Dec 4
Wed, Dec 3
Tue, Dec 2
Mon, Dec 1
Fri, Nov 28
Thu, Nov 27
Wed, Nov 26
Tue, Nov 25
Mon, Nov 24
Fri, Nov 21
Thu, Nov 20
Wed, Nov 19
Tue, Nov 18
Mon, Nov 17
Fri, Nov 14
Thu, Nov 13
Wed, Nov 12
Tue, Nov 11
Mon, Nov 10
Fri, Nov 7
Thu, Nov 6
Wed, Nov 5
Tue, Nov 4
Mon, Nov 3
Fri, Oct 31
Thu, Oct 30
Wed, Oct 29
Tue, Oct 28
Mon, Oct 27
Fri, Oct 24
Thu, Oct 23
Wed, Oct 22
Tue, Oct 21
Mon, Oct 20
Fri, Oct 17
Thu, Oct 16
Wed, Oct 15
Tue, Oct 14
Fri, Oct 10
Thu, Oct 9
Wed, Oct 8
Tue, Oct 7
Mon, Oct 6
Sat, Oct 4
Fri, Oct 3
Thu, Oct 2
Wed, Oct 1
Tue, Sep 30
Mon, Sep 29
Fri, Sep 26
Thu, Sep 25
Wed, Sep 24
Tue, Sep 23
Mon, Sep 22
Fri, Sep 19
Thu, Sep 18
Wed, Sep 17
Tue, Sep 16
Mon, Sep 15
Fri, Sep 12
Thu, Sep 11
Wed, Sep 10
Tue, Sep 9
Mon, Sep 8
Fri, Sep 5
Thu, Sep 4
Wed, Sep 3
Tue, Sep 2
Fri, Aug 29
Thu, Aug 28
Wed, Aug 27
Tue, Aug 26
Mon, Aug 25
Fri, Aug 22
Thu, Aug 21
Wed, Aug 20
Tue, Aug 19
Mon, Aug 18
Fri, Aug 15
Thu, Aug 14
Wed, Aug 13
Tue, Aug 12
Mon, Aug 11
Fri, Aug 8
Thu, Aug 7
Wed, Aug 6
Tue, Aug 5
Mon, Aug 4
Fri, Aug 1
Thu, Jul 31
Wed, Jul 30
Tue, Jul 29
Mon, Jul 28
Fri, Jul 25
Thu, Jul 24
Wed, Jul 23
Tue, Jul 22
Mon, Jul 21
Fri, Jul 18
Thu, Jul 17
Wed, Jul 16
Tue, Jul 15
Mon, Jul 14
Fri, Jul 11
Thu, Jul 10
Wed, Jul 9
Tue, Jul 8
Mon, Jul 7
Fri, Jul 4
Thu, Jul 3
Wed, Jul 2
Tue, Jul 1
Page 2/4

DON'T BUY

They do not take any credit risk. They are a transaction company, and with the move away from cash, MA will benefit. However, the valuation compared to their historic multiple is high. They used to trade at a market multiple. Now, it is at 2x the market multiple. It has been rerated. However, thinks it is stretched and any economic dislocation can see a big correction.

DON'T BUY

In the news for their vaccine. It's pretty much all their business right now. Total revenue was $60M, but their market cap is $170B. The question is, are their legs with the vaccine franchise. They have lots of drugs in their pipeline, but there is a lot of risk.

DON'T BUY

Years ago, it was the darling of the chip space. They have fallen on hard times. They still do $75B in business but they cannot get traction from a growth standpoint. Greatest attribute is the cheap valuation around 12x earnings. More a value trap. It could turn itself around. There are other better opportunities.

BUY

Capital market business is on fire in the US. There is tremendous amounts of liquidity. Goldman has been successful in this business. Chosen to go with other opportunities with banking, loan spreads, but still likes this.

BUY

Likes it. An aerospace company in defence. The aerospace part has not been doing well, but it is starting to get legs. The combined operation is still undervalued. They spin off a lot of cash. Should support growth in their capital allocation policy leading to higher dividends and stock buybacks.

BUY

Can buy now. A fairly recent entry to his portfolio. Always a mystery from a financial standpoint. Becoming more traditional in their accounting and how they allocate capital. New CEO that is investing heavily in distributions and fulfillment centres. More same day delivery is coming. Cloud business is the best in the world too. Getting involved with content and bought MGM now. A company that is growing quickly.

BUY

A public vehicle in the quasi-private business. Takes advantage of opportunities in the marketplace, hold them until they mature, and then sells them. They continue churning money. Incredibly successful at it. Can continue to hold the company. They pay out a percentage of their profit bases. Switched from a LP to a regular listed company. Continues to pay fairly large distributions.

DON'T BUY

A broad company with many types of drugs. Laws in the US stipulates that after spending millions of dollar for franchises, the drug will go off patent in time. Pharmaceuticals have been doing this for a long time.

DON'T BUY

Broadly, pharmaceuticals and healthcare space is not providing a ton of opportunity. Trading at reasonable valuations with 3 divisions. Consumer business is in trouble because more people are going towards generics. Pharma business hasn't seen much tailwind from covid vaccines.

COMMENT

He's been saying that the seasonal period starting today will be a rocky one. It was as stocks sank today. Also, bearish sentiment hasn't peaked since the Dotcom period. Also stocks pull back, you may need to buy into that decline. September/October seasonality is consistent. This year, supply chain constraints, the Delta effect and other worries are factors.

COMMENT

They report Monday. Excellent managers. He wants them to talk about supply shortages and home demand. Lennar is important to retail, banking and the hybrid work from home economy.

COMMENT

It reports Tuesday. It has been hit with a ton of negative commentary. Will they say anything to give us a reason to buy? We'll see.

BUY

It reports Tuesday. It's become the bellwhether of tech stocks. The stock has been on fire, because business is booming; their products are essential to e-commerce. He loves their suite of products.

BUY ON WEAKNESS

It reports Tuesday. Their last quarter was good. If shares got hammered Monday and Tuesday, maybe you can buy this lower on Wednesday.

BUY ON WEAKNESS

It reports Thursday. He doesn't expect good things. True, the stock has been rallying up in a straight line, but the clueless always expect an upside surprise, then sell it when numbers are merely in-line. A great company. He expects the clueless to sell it.

Wednesday, September 22, 2021 Tuesday, September 21, 2021 Monday, September 20, 2021 Friday, September 17, 2021 Thursday, September 16, 2021 Wednesday, September 15, 2021 Tuesday, September 14, 2021

Most Recent Experts

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Kevin Simpson

Capital Wealth Planning

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Michael Hakes - CFA, MBA

Murray Wealth Group

Stephanie Link, Chief investment strategist, Hightower

Hightower

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Latest Stock Buy or Sell? Make More Informed Decisions!

Mastercard Inc.(MA)

Moderna(MRNA)

Intel(INTC)

Goldman Sachs(GS)

Raytheon(RTX)

Amazon.com, Inc.(AMZN)

Blackstone Group LP(BX)

Pfizer Inc(PFE)

Johnson & Johnson(JNJ)

A Comment -- General Comments From an Expert(A Commentary)

Lennar Corp.(LEN)

FedEx(FDX)

Adobe Systems(ADBE)

Workday(WDAY)

Costco Wholesale Corporation(COST)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Kevin Simpson

Josh Brown, CEO, Ritholtz Wealth Management

Michael Hakes - CFA, MBA

Stephanie Link, Chief investment strategist, Hightower